Sujal M. Patel

CEO, President, and Secretary at Nautilus Biotechnology Inc.

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
4 years
Director since
2023

4 years of board service in total across 1 board, counting each seat separately. Longest: Nautilus Biotechnology Inc., 3 years.

Nautilus Biotechnology Inc. Director · CEO, President, and Secretary
3 years · Since 2023

Chief executive roles

Nautilus Biotechnology Inc. · CEO, President, and Secretary
Dates unknown

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Mar 4, 2026 Nautilus Biotechnology Inc. Open-market purchase +25,000 $2.61 $65,250
Sep 8, 2025 Nautilus Biotechnology Inc. Open-market purchase +83,500 $0.68 $56,780
Sep 5, 2025 Nautilus Biotechnology Inc. Open-market purchase +116,500 $0.67 $78,055
Mar 20, 2025 Nautilus Biotechnology Inc. Open-market purchase +23,933 $1.00 $23,933
Mar 19, 2025 Nautilus Biotechnology Inc. Open-market purchase +53,300 $0.99 $52,767
Mar 11, 2024 Nautilus Biotechnology Inc. Open-market purchase +12,044 $2.84 $34,205
Mar 8, 2024 Nautilus Biotechnology Inc. Open-market purchase +2,430 $2.99 $7,266
Mar 7, 2024 Nautilus Biotechnology Inc. Open-market purchase +18,854 $2.89 $54,488
Mar 6, 2024 Nautilus Biotechnology Inc. Open-market purchase +9,267 $2.70 $25,021
Mar 5, 2024 Nautilus Biotechnology Inc. Open-market purchase +7,405 $2.65 $19,623

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.